4//SEC Filing
Gionco David 4
Accession 0001104659-19-015343
CIK 0001264587other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 9:00 PM ET
Size
8.0 KB
Accession
0001104659-19-015343
Insider Transaction Report
Form 4
Gionco David
Chief Accounting Officer
Transactions
- Sale
Common Stock
2019-03-11$11.11/sh−13,492$149,896→ 225,468 total - Sale
Common Stock
2019-03-12$11.05/sh−530$5,857→ 224,938 total
Footnotes (5)
- [F1]In connection with the vesting of 9,398 shares on March 8, 2019, and 17,575 shares on March 9, 2019, a total of 14,022 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sales, which were conducted automatically in accordance with the issuer's corporate policies.
- [F2]Reflects the weighted average sale price. The range of prices for such transaction is $11.00 to $11.53. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Of the 225,468 shares, 174,907 shares are restricted stock.
- [F4]Reflects the weighted average sale price. The range of prices for such transaction is $11.05 to $11.25. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Of the 224,938 shares, 174,907 shares are restricted stock.
Documents
Issuer
STEMLINE THERAPEUTICS INC
CIK 0001264587
Entity typeother
Related Parties
1- filerCIK 0001456864
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 9:00 PM ET
- Size
- 8.0 KB